Provision of a Multiplex Fluorescence Scanner with quantitative pathology imaging and analysis

Description

Award to Akoya Biosciences for the purchase of a multiplex fluorescence slide scanner with quantitative pathology imaging and analysis to be used in the Research Department, Porton. Lot 1: The provision of a Multiplex Fluorescence Scanner will enable UK HSA to produce quantitative multiplex image analysis, with elements of the application of artificial intelligence in pathology (advance image analysis, such as tissue classification, phenotyping or pattern recognition) to be applied to ongoing and future research projects focusing on high priority activities including COVID19, Ebola, Zika, Crimean Congo Haemorrhagic Fever, Chikungunya, Zika virus infection, Q Fever, Anthrax, Tuberculosis, Monkeypox, Influenza, Pertussis, Meningococcal disease, Anti-Microbial Resistance, etc.<br/><br/>The Research team is responding to the COVID19 outbreak by delivering the pathology component of every pre-clinical experiment carried out at Porton, including vaccines and therapeutics against SARS-CoV-2. This work is supporting the UKHSA Infectious Disease Strategy, in the development of interventions against disease, and particularly at the moment support our strategy of being ready to respond to Pandemics as part of the current international global response.